Histiocytosis X is a systemic disease of unknown etiology which affects almost every organ with pathological proliferation of reticuloendothelial cells, varying from histiocytic infiltration to granulomatous changes, to healing fibrosis (Lichtenstein, 1953) .
Since histiocytic invasion in the central nervous system is usually limited to the hypothalamus, pituitary stalk and/or posterior pituitary, patients with this disorder may manifest clinical diabetes insipidus, anterior pituitary dysfunction and so forth (Avery et al., 1957; Helbock et al., 1971; Braunstein et al., 1972a, b) . Such patients, therefore, provide a unique model for studying hypothalamic regulation of pituitary tropic hormone secretion in man.
This report describes a patient with diabetes insipidus caused by histiocytosis X, LH (Odell et al., 1967) , FSH (Midgley, 1967) and HPr were determined by the specific radioimmunoassays. Highly purified human ACTH (Li), HGH (Wilhelmi), TSH (Calbiochem), HPr (Friesen) , LH and FSH (the Second International Reference Preparation of Human Menopausal Gonadotropin; 2nd IRP-HMG, National Institute for Medical Research.) were used for standards.
Total serum thyroxine and plasma cortisol were determined by competitive protein-binding assays (Murphy and Pattee, 1964; Murphy, 1967) .
The total 24 hr. urinary 17-hydroxycorticosteroid (17-OHCS) was measured by the method of Silber and Porter (1954) .
Plasma and urinary osmolarity were determined by Fiske osmometer (freezing-point depresion) and blood glucose by Technicon Auto Analyzer.
Case Report
The patient, 44-year-old female, was admitted to this hospital in May, 1973, for further evaluation of her diabetes insipidus, intractable to conventional treatment.
She was well until September, 1970, when she noticed abrupt onset of thirst, always craving for cold water, accompanied by polyuria with daily urinary volume over 10 liter.
On the first admission to another hospital in May, 1971, the diagnosis of diabetes insipidus was made without further evaluation of its etiology, and she was discharged in June, 1971 (Fig.2.) . The same changes were recognized in the bone lesion, though regressing and replaced by fibrosis (Fig.4.) course, suggestive of hyperprolactinemia resulting from hypothalamic involvement, which was proven later by hypothalamic-pituitary function studies. She was treated with prednisolone 30mg/day as soon as the diagnosis was established and all endocrine studies completed. The steroid regimen had a dramatic effect, resulting in complete disappearance of her systemic symptoms and signs.
She gained wellbeing, good appetite, and disappearance of fever with normal erythrocyte sedimentation rate and negative CRP reaction, although her galactorrhea and hyperprolactinemia persisted. On steroid treatment, her diabetes insipidus was controlled with a combination of chlorpropamide (500mg/day) and hydrochlorothiazide (100mg/day). She is now, two years after discharge, doing well without recurrence.
Results

Posterior pituitary function
The patient failed to concentrate her urine above the level of plasma osmolarity after 7 hr water deprivation.
The final ratio of urinary to plasma osmolarity (Uosm/Posm) was 0.39, extremely low, indicating impaired anti-diuretic function. The vasopressin test at the first admission, which was not performed on this occasion because of her allergic history, demonstrated a significant rise of Uosm (from 181 to 480 mOsm/kg) following intramuscular injection of 5U pitressin tannate in oil.
2. Anterior pituitary function a) Hypothalamic-pituitary-adrenal function 24 hr urinary excretion of 17-OHCS was 6.5mg. Circadian rhythm of plasma ACTH, elevated early in the morning and fallen in the evening, was noted (Fig.5) . Synthetic e) HPr secretion Basal HPr levels were persistently elevated, ranging from 44 to 80ng/ml. No increment of HPr secretion occurred following TRH stimulation. Furthermore, plasma HPr levels were not suppressed by either l-DOPA administration or water loading, the maneuvers known to inhibit pituitary prolactin secretion in normal subjects. Administration of CB-154, however, resulted in a significant fall of plasma HPr levels (Table 4 ).
Discussion
The patient described here exhibited the clinical, radiological and pathological diagnosis of histiocytosis X (Lichtenstein, 1953; Avery et al., 1957) . A unique feature presented by this patient was the spontaneous galactorrhea which developed during the course. Since histiocytic involvement is usually limited to the hypothalamns, pitui- (Avery et al., 1957; Helbock et al., 1971; Braunstein and Kohler, 1972b) , this patient provided a unique opportunity to investigate the effect of the hypothalamic lesion on pituitary function.
Pituitary-adrenal axis was normal so far as 24 hr urinary 17-OHCS excretion and adrenal responsiveness to ACTH were concerned. ACTH secretion modulated by the mechanism of circadian rhythmicity and negative feedback seemed to remain intact. The lack of ACTH secretion during insulininduced hypoglycemic stress raises two possibilities. First, the hypothalamic areas regulating corticotropin releasing factor (CRF) might be partially involved by histiocytic invasion since the dissociation of impaired ACTH secretion by different stimuli is reported (Faglia et al., 1973) . Second, the present results of hypoglycemic stress might be invalid because the elevated basal level of plasma cortisol may not preclude the fortuitous unresponsiveness to the provocation. Therefore, repeated tests with hypoglycemic stress or other provocations, such as lysine-vasopressin and pyrogen, should be performed under the basal state to solve these possibilities. On the other hand, HGH failed to secrete during any of the provocation tests performed, indicating complete involvement of the hypothalamic areas to release growth hormone releasing factor (Braunstein et al., 1972a, b; Gates et al., 1973) . Hypothalamic-pituitary-thyroidal axis, however, was well preserved, indicating no involvement. The results of both low basal levels of plasma gonadotropin and response of gonadotropin secretion, though limited, to LH-RH administered intravenously, strongly suggested the secondary dysfunction of anterior pituitary resulting from long-term LH-RH deficiency.
Basal HPr was found to be persistently elevated as expected from the spontaneous galactorrhea.
HPr secretion is believed to be regulated predominantly by hypothalamic prolactin inhibiting factor (PIF) (Turkington et al., 1971; Meites et al., 1972 To our knowledge, this patient with histiocytosis X was the first case reported in which thorough endocrine studies were performed, using radioimmunoassay techniques to measure the pituitary tropic hormones known at present. In a series of 13 patients with Hand-Schuller-Christian disease (Braunstein and Kohler, 1972b) , impaired secretion of HGH was found in 10 patients in whom diabetes insipidus was usually present. These results are in agreement with ours. Later studies (Braunstein et al., 1972a) , showed that 8 of 13 patients exhibited hyperprolactinemia and the elevated plasma levels of HPr in 3 of 8 patients were not suppressed by administration of l-DOPA. These 3 patients might have the same hypothalamic lesions as the present case, in whom inappropiate function of the hypothalamus to release PIF in response to those stimuli was suggested. The patient reported by Gates et al.(1973) had also hyperprolactinemia, although further evaluation was not performed. Their autopsy findings, however, were interesting; focal histiocytic infiltration was found in the posterior hypothalamus, whereas almost complete replacement by histiocytic infiltration was found in the posterior pituitary. The anterior pituitary was spared from involvement, being abundant in prolactin producing cells and deficient in GH producing cells. Therefore, similar pathological changes are expected to be found in the hypothalamus of the present case.
In conclusion, thorough investigation of hypothalamic pituitary function in patients with this disorder is useful to assess the extent of histiocytic infiltration in the hypothalamus, and to study the hypothalamic regulation of pituitary tropic hormone secretion in man.
